TD Securities (USA) LLC has disclosed a 4.6% ownership stake in OneMedNet Corp, as detailed in a recent SEC filing. This update is significant as it highlights the growing interest in OneMedNet, a company operating in the commercial physical and biological research sector. The filing reflects ongoing investment dynamics in the industry, which is characterized by active competition and innovation.

Background

OneMedNet Corp, identified under the SIC code 8731, specializes in services related to commercial physical and biological research. The company trades on the Nasdaq under the ticker symbols ONMD and ONMDW. Recently, OneMedNet has been active in the market, with multiple filings indicating a strategic focus on growth and investment.

What the Filing Says

The Schedule 13G/A filing, dated November 13, 2026, reveals that TD Securities (USA) LLC beneficially owns 292,156 shares of OneMedNet's common stock. This ownership is linked to warrants that are currently exercisable. The filing states, "The beneficial ownership of the Reporting Person is comprised solely of 292,156 shares of Common Stock issuable upon the exercise of warrants to purchase shares of Common Stock." This ownership percentage is calculated based on 6,012,591 shares of common stock deemed outstanding.

Impact

This stake may affect various stakeholders, including existing shareholders and potential investors, as it indicates a level of confidence from TD Securities in OneMedNet's future prospects. The filing also mentions other entities related to TD Securities, including Toronto Dominion Holdings USA Inc, TD Group US Holdings LLC, and The Toronto-Dominion Bank, which collectively hold interests in the reported shares.

What's Next

The filing does not specify what actions will follow this disclosure, leaving the market to speculate on potential future developments.